Company record
Xcelthera, Inc. manufactures biopharmaceutical products aimed at treating neurological and cardiovascular diseases. Its offerings include pluripotent‑stage human embryonic stem cell (hESC) culture systems and a suite of clinical‑grade, high‑purity cell types: human neuronal progenitors, mature human neurons, heart precursors, and cardiomyocytes.
This directory record does not yet have a linked material-flow brief.